Pricing Log in Create free account

Curis, Inc. (CRIS) vs 9 Meters Biopharma, Inc. (MNTRQ)

Curis, Inc. and 9 Meters Biopharma, Inc. are both Biotechnology companies. Curis, Inc. and 9 Meters Biopharma, Inc. are of similar size ($1.1M and $1.0M). Curis, Inc. grew revenue faster over the last twelve months: −13.4% against −50.8%. Across the 12 metrics below, Curis, Inc. leads on 7 and 9 Meters Biopharma, Inc. on 5.

Valuation

Metric CRIS MNTRQ Biotechnology median
P/E n/m n/m 8.50
P/S 0.09 0.07 9.71
P/B 0.19 n/m 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.41 0.05 0.64
EV/Sales (0.37) (0.54) 9.21
Earnings yield (3,468.29%) (17,300.00%) (33.15%)
Free cash flow yield (3,540.29%) (13,701.96%) (25.50%)

Profitability

Metric CRIS MNTRQ Biotechnology median
Gross margin 99.52% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 455.35% (375.64%) (56.36%)
Return on assets (87.76%) (190.56%) (48.04%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CRIS MNTRQ Biotechnology median
Revenue growth (TTM) (13.43%) (50.82%) 6.02%
EPS growth (last fiscal year) 91.57% (12.67%) 30.26%
Revenue growth, 5-year CAGR (2.71%) — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CRIS MNTRQ Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 0.49 0.59 4.72
Net debt to EBITDA 0.91 0.31 0.96

Dividend

Metric CRIS MNTRQ Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CRIS MNTRQ Biotechnology median
Market cap 1.06m 1.04m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack